Has Ajar Kochar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,716 in general payments to Ajar Kochar, MD across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ajar Kochar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ajar Kochar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ajar Kochar, MD

Interventional Cardiology · Baltimore, MDNPI 1477843233

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $17,150 of the $21,716 with a category attached, or 79.0%. Abiomed accounts for 85.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $15,580 and has fallen 90.7% since, to $1,455 in 2025.

$21,716in general payments, 2019–2025

Across 57 payments — averaging $380.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$19K
Spectrawave, Inc$800
Abbott$650
Endovascular Engineering Inc.$566
Stryker$328
Shockwave Medical, Inc$261
plus $494 from 9 others

$140,761in research payments, 2019–2025

Across 33 payments — averaging $4265.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Shockwave Medical, Inc$60K
Endovascular Engineering Inc.$29K
Livanova USA, Inc.$19K
Boehringer Ingelheim$17K
Chiesi USA, Inc.$13K
Boehringer Ingelheim International GmbH$2K
plus $68 from 1 others

What the payments were for

Consulting fees$8004%
Speaking & faculty fees$17,15079%
Travel & lodging$1,9059%
Food & beverage$1,8609%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	9	$18,616
Spectrawave, Inc	2	$800
Abbott	15	$650
Endovascular Engineering Inc.	2	$566
Stryker	9	$328
Shockwave Medical, Inc	7	$261
Livanova USA, Inc.	1	$133
Philips North America LLC	1	$125
Amgen	3	$65
Boston Scientific	2	$43
Inari Medical, Inc.	2	$37
Cordis US CORP.	1	$31
Heartflow, Inc.	1	$23
Novo Nordisk	1	$22
Cardiovascular Systems Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,716 in reported general payments places this provider in the 75th percentile of 71 interventional cardiology providers in Maryland.

See all interventional cardiology providers in Maryland →

Medicare billing

Part B allowed, 2024

$86,721

Medicare patients

207

Services billed

517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	62	$49,649
JardianceEmpagliflozin	22	$23,677
EntrestoSacubitril/Valsartan	14	$11,061
Rosuvastatin Calcium	76	$2,871
Ezetimibe	72	$2,531
Metoprolol Succinate	68	$1,009
Atorvastatin Calcium	66	$989
Eplerenone	12	$613
Chlorthalidone	15	$385
Isosorbide Mononitrate ErIsosorbide Mononitrate	21	$307
Carvedilol	32	$277
Potassium Chloride	19	$265
Nifedipine ErNifedipine	11	$198
Amlodipine Besylate	41	$187
Losartan Potassium	21	$180

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Baltimore

Aloke FinnBaltimore$575K
John WangBaltimore$138K
Diljon ChahalBaltimore$78K
Jon ResarBaltimore$40K
Faisal RahmanBaltimore$36K
Matthew VossBaltimore$33K
Hooman BakhshiBaltimore$32K
Daniel AmbinderBaltimore$32K
Rani HasanBaltimore$22K
Hani AlkhatibBaltimore$19K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →